MDxHealth
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
16 okt 2007 - 08:30
Statutaire naam
MDxHealth
Titel
OncoMethylome Sciences Engaged in Private Share Offering
Bericht
Liege (Belgium) – October 16, 2007, 8:15 CET – OncoMethylome Sciences SA (Euronext Brussels: ONCOB, Euronext Amsterdam: ONCOA) has engaged in a private placement of new shares.
OncoMethylome has instructed investment bankers to initiate a private accelerated bookbuild offering to institutional and qualified investors with a view to placing new shares for an approximate amount of €8 million, or possibly more, but not more than 10% of the presently outstanding shares. The funds will be used to finance the execution of OncoMethylome’s business plan, especially the clinical trials that are necessary for developing OncoMethylome’s novel cancer diagnostic products and personalized cancer treatment tests.
The company will announce the results of the offering as soon as possible after closing of the book building.
Gerelateerde downloads
Datum laatste update: 02 september 2024